Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
433
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+4.71M
-
Total reported value, excl. options
-
$5.98B
-
Value change
-
+$254M
-
Put/Call ratio
-
0.48
-
Number of buys
-
210
-
Number of sells
-
-190
-
Price
-
$53.64
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2024
489 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2024.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 433 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 115M outstanding shares and own 96.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11M shares), BlackRock Inc. (10.9M shares), JANUS HENDERSON GROUP PLC (7.66M shares), STATE STREET CORP (3.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), Bank of New York Mellon Corp (3.02M shares), Champlain Investment Partners, LLC (2.5M shares), Camber Capital Management LP (2.5M shares), Burgundy Asset Management Ltd. (2.48M shares), and HAWK RIDGE CAPITAL MANAGEMENT LP (2.37M shares).
This table shows the top 433 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.